What about Shandong innovative drug R&D Co., Ltd.?

Shandong Innovation Pharmaceutical R&D Co., Ltd. is mainly engaged in the research and development of new drugs such as chemical drugs, biomedicine and natural drugs. At the same time, our company is also "Shandong Psychotropic Drug Engineering Technology Research Center".

1, excellent R&D team.

The company takes talent development as the core, and currently has 45 employees, including 42 with bachelor degree or above, 7 with master degree and 7 with doctor degree. Senior title 10, intermediate title 20; The academic committee of the company is composed of 65,438+00 famous domestic experts, and Professor Hong Tao, an academician of China Academy of Engineering, is the chairman.

The company has achieved good results in introducing high-level talents. Academician Hong Tao, a high-level talent introduced by the company, served as the chief scientist, and was listed as the city's 5 150 high by the Jinan Municipal Party Committee and Municipal Government.

Level-1 talent program, awarded certificates, and allocated 1.5 million yuan for scientific research.

Our company is actively introducing Dr. Wei, director and associate professor of molecular and gene therapy at Griffith University School of Medicine in Australia, to collect and sort out relevant information about Dr. Wei. Recently, we declared Jinan 5 150 plan to introduce high-level talents and registered Shandong Xing Health Pharmaceutical Co., Ltd. for him. In the second half of the year, Dr. Wei applied for the plan of introducing 10,000 high-level talents to the province, and strived to enter the first and second ranks.

2. Strict quality control.

The company takes quality control as the core, regards ensuring the quality of project research and development as the life of the company, establishes and improves the quality inspection and control system, and ensures that the project test and data quality fully meet the national standards.

3. Advanced scientific research equipment.

The company has 6 sets of famous brands such as Agilent, Shimadzu and Hitachi. , including gas chromatograph, preparative liquid chromatograph, ultraviolet-visible spectrophotometer, electronic balance (2 sets), automatic polarimeter, freeze dryer, dissolution instrument, injection, filling and sealing machine, constant temperature and humidity box, rotary evaporator, GSH-20L high-pressure reactor, electric blower drying box, liquid nitrogen tank for strain preservation and anaerobic reactor.

4. Standardized experimental facilities

According to the requirements of the National Measures for the Administration of New Drug R&D Registration, the company has set up standard synthesis laboratories, analytical laboratories, preparation laboratories, microbiology laboratories, traditional Chinese medicine and natural medicine laboratories, as well as lean and efficient new drug R&D center, market development department, financial secretary department and other functional departments.

5. Perfect management mechanism.

The company has established more than 40 management systems, such as project establishment procedures, laboratory management regulations, employee incentive measures, technology transfer measures, safety and health management responsibility system, financial management regulations, confidentiality, employee recruitment, attendance, etc., so that the company's management has rules to follow and its operation is standardized.

6. Good cooperation.

The company develops itself with the help of external brain and external force. At present, the company has established good communication and cooperation with famous universities, scientific research units and well-known pharmaceutical production enterprises at home and abroad. Such as Shandong University, Shandong Academy of Medical Sciences, Beijing Founder Institute of Medicine, Shandong Qilu Pharmaceutical, Jilin Amendment Pharmaceutical, Beijing Huasu Pharmaceutical, Nanjing simcere, etc. , as well as Harvard Medical School in the United States, Griffith University Medical School in Australia and Hebrew University Medical School in Jerusalem, Israel.

7. Rich scientific research achievements

Since its establishment, the company has developed more than 30 new drug projects, signed more than 0 technology transfer contracts/kloc-0 with pharmaceutical companies, independently applied for 8 national new drug projects, obtained 20 acceptance numbers, obtained 3 clinical trial varieties approved by the state and 7 approvals.

Projects under preparation: 8 chemical drugs, 2 biomedical projects (anti-Alzheimer's disease monoclonal antibody research and biological targeted tumor lysis clinical research), 2 traditional Chinese medicines and natural medicines (Qingshan Jianxin tablet research and development, extraction and separation of licorice isoflavones and pharmacological effects).

At present, it undertakes 8 scientific research projects in national, provincial, Jinan and high-tech zones. These projects are being carried out as planned, and preliminary research results have been achieved, which greatly encouraged the morale of the company's employees and promoted the company's research and development work.

The company has achieved good economic and social benefits. Since 2009, the total amount of technology transfer contracts signed is nearly 20 million yuan, and the capital gains are more than 8 million yuan. It is estimated that the capital gains in 20 1 1 year will exceed 8 million yuan. This laid a good foundation for the company's rapid development.

Legal Representative: Jiang Hong.

Date of establishment: June 2008-10

Registered capital: 20 million yuan.

Location: Shandong Province

Unified social credit code: 91370100676807816r.

Business status: in-service (opened) enterprises.

Industry: scientific research and technical services

Company type: other limited liability companies

English name: Shangdong Chuangxin Pharmacy R&; D ltd.

Personnel size: 50-99 people

Enterprise address: Room 160 1 Jinan Medicine Valley, North Section of Xinggang Third Road, High-tech Zone, Jinan City, Shandong Province.

Business scope: technology development, technology transfer and technical consultation of Chinese and western new drugs, raw materials, pharmaceutical intermediates, health products, functional foods, chemical reagents, disinfectants, sanitary products, chemical products and new veterinary drugs (excluding dangerous chemicals). (Projects subject to approval according to law can only be operated after approval by relevant departments)